Home/Filings/4/0001104659-11-068452
4//SEC Filing

McBarron Paul 4

Accession 0001104659-11-068452

CIK 0001130166other

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 6:33 PM ET

Size

5.3 KB

Accession

0001104659-11-068452

Insider Transaction Report

Form 4
Period: 2011-12-06
McBarron Paul
DirectorEVP, Finance, CFO, COO
Transactions
  • Award

    Common Stock, $0.001 par value per share

    2011-12-06+75,000263,054 total
Footnotes (3)
  • [F1]These shares of common stock are represented by restricted stock units which will vest on the third anniversary of the grant date.
  • [F2]These securities were issued as part of the Issuer's annual equity compensation to executive officers under the Issuer's Amended and Restated 2006 Equity Incentive Plan.
  • [F3]Of the shares of common stock reported, 75,000 shares are represented by unvested restricted stock units and 12,492 shares are represented by restricted stock subject to forfeiture until vested.

Documents

1 file

Issuer

Cyclacel Pharmaceuticals, Inc.

CIK 0001130166

Entity typeother

Related Parties

1
  • filerCIK 0001357397

Filing Metadata

Form type
4
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 6:33 PM ET
Size
5.3 KB